Navigation Links
Cephalon Quarterly Conference Call Invitation
Date:3/31/2008

First Quarter 2008 Earnings Conference Call Thursday, May 1, 2008, 5:00

p.m. U.S. EDT

FRAZER, Pa., March 31 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering first quarter 2008 results for 5:00 p.m. EDT on Thursday, May 1, 2008.

May 1, 2008 Schedule

4:10 p.m. EDT Q1 2008 results will be distributed by PRNewswire

4:50 p.m. EDT To participate in the conference call, dial 913-981-5581

and refer to Conference Code Number 7561641

5:00 p.m. EDT Conference call begins promptly.

Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at http://www.cephalon.com and clicking on "Investor Information" then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until Midnight EDT, May 14, 2008. To listen to the audio replay, dial 719-457-0820 and use the Conference Code Number 7561641.

Additional information presented on the conference call may be made available on the Investor Information page of the company's website.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
2. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
3. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
4. Cephalon General Counsel John E. Osborn to Resign Position
5. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
6. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
7. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Submits Supplemental New Drug Application for FENTORA
10. Cephalon Announces Strong Third Quarter Financial Results
11. Cephalon Quarterly Conference Call Invitation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BEIJING,Nov.25/PRNewswire-Asia/--SinovacBiote...s,announcedtodaythatitexecuted,ajointventure(JV)ag...yCo.,Ltd.(SinovacDalian).TheJVwillresearch,develop...willcontributeitsexpertise,andexperienceindevelopi...artywillbringitslanduserights,manufacturingfacilit...
(Date:11/24/2009)..., HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Nas...dcommunicationssystemsandservicesforthecommercial,...itscommercialbusinessgrouphasbeenawardedacontractf...ortheLevel4bio-safetylab(BSL-4)replacementfacility...iseases(USAMRIID)atFortDetrickinFrederick,Md. ,...
(Date:11/24/2009)..., CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswire-...sacquiringtheassetsofHylandSeeds,adivisionofThomps...edswillfurtherexpandDowAgroSciences,currentseedsbu...rtStax(TM) in 2010 andDowAgroSciencesHerbicideTo...closeisexpectedinthenearfuture. ,, "Thisacquisi...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-First...ouncedtheapprovalofallofits,"firstday"motionsbythe...ankruptcyCourt").deCODElastweekfiledavoluntarypeti...uptcyCodewiththe,BankruptcyCourt. , Theorders...e,tooperateitsbusinessduringtheChapter11proceeding...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...ticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced ...ive Officer, is scheduled to present at,the Rodman.... Mr. Bentsur,will present an overview of the Comp...any,s late-stage clinical compound for the treatme...sentation will take place on,Tuesday, May 20, 2008...
...p,(Debiopharm), a global independent biopharmaceut...dical conditions and particularly oncology, announ...long-term European,pharmaceutical partner, for the...ation, a gonadotropin releasing hormone (GnRH) ago... sexual deviations in adult men by,inducing and ma...
...ical engineers have created experimental solar cel... efficient thin-film solar cells of the future. , ...ctron superhighways that carry electrons kicked lo...ectron-attracting electrode and this scenario cou...g to research recently published in NanoLetters. ...
Other Biology Technology:XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations 2Nanowires may boost solar cell efficiency, UC San Diego engineers say 2Nanowires may boost solar cell efficiency, UC San Diego engineers say 3Nanowires may boost solar cell efficiency, UC San Diego engineers say 4
(Date:11/25/2009)...A, CAWhen you eat may be just as vital to your hea... Institute for Biological Studies. Their experimen...ng of thousands of genes in the liverthe body,s me...intake and not by the body,s circadian clock as co...termines the activity of a large number of genes c...
(Date:11/24/2009)... Research Institute (LRI) today named 12 new grant...llion, recognize innovative work across a broad sp...eir creativity, novelty, and potential to drive sc...nd cure the complex disease of systemic lupus. , ...pus researchers across the nation and include inte...
(Date:11/24/2009)...s have crystallised a protein that may help gut ba...tein could be used by probiotic producers to ident...to people. , "Probiotics need to interact with ce...d if they attach to surfaces in the gut they are m...eir activity," says Dr Nathalie Juge from the Inst...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Associated Press Cites Mexico as Example of H1N1 Success 56031 1Pittsburgh G 2O Explained 3A Watch Penn State Experts on YouTube 56028 1Pittsburgh G 2O Explained 3A Watch Penn State Experts on YouTube 56028 2SHPS Wins Nine Healthcare Communication Awards in the 2009 Health Information Awards Program 56025 1SHPS Wins Nine Healthcare Communication Awards in the 2009 Health Information Awards Program 56025 2
...ted for its wood and cottony fibers, the kapok tre...ung to for decades: the notion that African and So...ontinents were connected 96 million years ago. , R...logist Christopher Dick and colleagues shows that ...zed Africa after the continents split when the tre...
...ty have used genetic modification to successfully ...that it’s possible to create miniature trees that ...ears of growth may range anywhere from 50 feet tal...that tree height can be readily controlled by gene... wide variety of new products for the ornamental a...
...n advance of its July 1st publication date, Drs. N...k Institute and HHMI) demonstrate that endosomes c...ell as in animals. , "These findings will influenc...somes and hopefully help us to understand why cell...author of the paper, Dr. Niko Geldner. , Endoso...
Other Biology News:The kapok connection -- Study explains rainforest similarities 2Researchers demonstrate way to control tree height 2Researchers demonstrate way to control tree height 3
Mouse Anti-Fatty Acid Binding Protein (FABP) Antibody, TRITC (Rhodamine) Conjugated from HyTest Ltd.
... form: Solution in 50% glycerol containing 20 mM T...aration Unit Definition: One unit will digest soni...otides equivalent to a ΔA 260 of 1.0 in 30 m...ssay: SDS-PAGE ≥ 90 % Concentration: ≥ 250 ...
Mouse Anti-Human BTG2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Rabbit Anti-NMDA NR2B, phospho (Tyr1336) Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: